VIRUS FILTRATION MARKET ANALYSIS

Regional Analysis

Global Virus Filtration Market: Regional Insights

Based on geography, the global virus filtration market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period due to the rise in prevalence of chronic diseases, growing demand for therapeutic biologics, increase in research and development, and rapid growth of the pharmaceutical and biotechnology industry in the region. Therapeutic biologics are often used for the treatment of chronic diseases. For instance, according to the Centers for Disease Control and Prevention (CDC), six in ten adults in the U.S. live with at least one chronic disease and are the leading causes of death and disability in America, and they are also a leading driver of health care costs.

Europe and Asia Pacific are also expected to witness lucrative growth in the global virus filtration market due to the increase in burden of chronic diseases, growing demand for biologics, and rapid growth of the pharmaceutical/biotechnology industry in these regions. For instance, virus filtration is used to assure the viral safety of pharmaceutical and biopharmaceutical processes. According to the India Brand Equity Foundation (IBEF), India is the largest producer of vaccines worldwide, accounting for 60% of the total vaccines, as of 2021. India supplies over 50% of the global demand for various vaccines, 40% of the generic demand for U.S. and 25% of all medicines for U.K.

• North America: U.S. and Canada
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Middle East and Africa: GCC Countries, Israel, Rest of Middle East, South Africa, North Africa, and Central Africa